International Clinical Trial: A Study to Establish the Bioequivalence of Free Acid Tafamidis 61 mg Capsule and Tablet, and Evaluate the Safety and Tolerability of the 61 mg Tablet in Healthy Adults Under Fed Conditions

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (CTIS2026-525342-29-00) titled 'A Study to Establish the Bioequivalence of Free Acid Tafamidis 61 mg Capsule and Tablet, and Evaluate the Safety and Tolerability of the 61 mg Tablet in Healthy Adults Under Fed Conditions' on Feb. 5.

Study Type: Interventional clinical trial of medicinal product

Study Design: Controlled: no Randomised: no Open: no Single blind: no Double blind: no Parallel group: no Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: no Placebo: no Number of treatment arms in the trial:

Primary Sponsor: Pfizer Inc.

Condition: Transthyretin amyloidosis MedDRA version: 20.0Level: PTCla...